Ceria Halim

Dr. Ceria Halim

Universitas Sumatera Utara, Medan, Sumatera Utara, Indonesia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
CHCeria Halim
Ceria Halim
AMAudrey Fabianisa Mirza
Audrey Fabianisa Mirza
MSMutiara Indah Sari
Mutiara Indah Sari
Background: An increasing number of scientific journals have proposed a connection between tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) and the severity of COVID-19. Vitamin D has been discussed as a potential therapy for COVID-19 due to its immunomodulatory effects. This meta-analysis aims to determine the relationship, if any, between TNF-α, IL-6, vitamin D, and COVID-19 severity and mortality. Methods: The design of the study is a systematic review and meta-analysis. A literature search is performed using PubMed, Cochrane, ProQuest, and Google Scholar. Results: TNF-α insignificantly increases the risk of COVID-19 severity (adjusted odds ratio (aOR) = 1.0304; 95% CI 0.8178–1.2983; p = 0.80) but significantly increases the risk of COVID-19 mortality (crude hazard ratio (HR) = 1.0640; 95% CI 1.0259–1.1036; p = 0.0009). IL-6 significantly increases the risk of COVID-19 severity (aOR = 1.0284; 95% CI 1.0130–1.0441; p = 0.0003) and mortality (aOR = 1.0076; 95% CI 1.0004–1.0148; p = 0.04; adjusted hazard ratio (aHR) = 1.0036; 95% CI 1.0010–1.0061; p = 0.006). There is a statistically insignificant difference of the mean vitamin D levels between patients with severe COVID-19 and non-severe COVID-19 (mean difference (MD) = −5.0232; 95% CI 11.6832–1.6368; p = 0.14). A vitamin D deficiency insignificantly increases the risk of mortality of COVID-19 patients (aOR = 1.3827; 95% CI 0.7103–2.6916; p = 0.34). Conclusion: IL-6 is an independent prognostic factor towards COVID-19 severity and mortality.

25 March 2024 in medRxiv
Verified
Preprint
Open access
PDF file
CHCeria Halim
Ceria Halim
MHMiranda Howen
Miranda Howen
AFAthirah Amirah Nabilah Binti Fitrisubroto
Athirah Amirah Nabilah Binti Fitrisubroto
TPTimotius Pratama
Timotius Pratama
IHIndah Ramadhani Harahap
Indah Ramadhani Harahap
ASAndre Marolop Pangihutan Siahaan
Andre Marolop Pangihutan Siahaan
Background Mediterranean Diet has been reported to possess immunomodulatory and anti-inflammatory properties. These properties are closely associated with the immunopathogenesis of COVID-19. Objective The present systematic review aimed to determine the association between Mediterranean Diet and COVID-19, COVID-19 symptoms, and COVID-19 severity. Methods The protocol for this systematic review was registered in International Prospective Register of Systematic Reviews (PROSPERO) with identification number CRD42023451794. The literature search was conducted through Pubmed, Proquest, and Google Scholar on August 2023. The inclusion criteria were studies with a population of human subjects, reported the association between Mediterranean diet adherence with risk of COVID-19 infection, COVID-19 symptoms, or COVID-19 severity, and full text must be available in English. The exclusion criteria were reviews, editorials, letters, replies, systematic reviews, meta-analyses, studies on animals, and duplicates. Risk of bias in included studies was assessed using Newcastle Ottawa Scale (NOS). Data was synthesized narratively. Each study was compared and a structured summary was developed. Results After selection process, 6 articles were included, with a sample size of 55,489 patients. All studies were observational studies and assessed Mediterranean diet adherence using food frequency questionnaires (FFQ), with scoring system varied between each study. Four studies found a significant correlation between increased adherence to Mediterranean Diet and reduced COVID-19 risk, while one study indicated non-significant association. One study reported a significant association between higher adherence to Mediterranean Diet and COVID-19 symptoms, but three studies reported non-significant association. One study found that individuals with higher adherence to Mediterranean Diet had reduced likelihood of developing severe COVID-19, however, two studies yielded inconclusive findings. Limitations All studies used self-administrated food frequency questionnaires (FFQs), which were prone to biased responses, such as recall and estimation bias. Discussion Lower trends of odds ratios (ORs) were consistently observed in higher Mediterranean diet adherence. In every outcome of the included studies, ORs ranged between 0.06-0.992, however, differing levels of significance were reported in each outcome. Conclusion Overall analyses suggest that high adherence to Mediterranean Diet is a protective factor against COVID-19, with unclear benefits against COVID-19 symptoms and severity. Primary Funding Source The author(s) received no specific funding for this work.

21 August 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CHCeria Halim
Ceria Halim
MHMiranda Howen
Miranda Howen
AFAthirah Amirah Nabilah Binti Fitrisubroto
Athirah Amirah Nabilah Binti Fitrisubroto
TPTimotius Pratama
Timotius Pratama
IHIndah Ramadhani Harahap
Indah Ramadhani Harahap
ASAndre Marolop Pangihutan Siahaan
Andre Marolop Pangihutan Siahaan
Background: Mediterranean Diet has been reported to possess immunomodulatory and anti-inflammatory properties. These properties are closely associated with the immunopathogenesis of COVID-19. Objective: The present systematic review aimed to determine the association between Mediterranean Diet and COVID-19, COVID-19 symptoms, and COVID-19 severity. Methods: The protocol for this systematic review was registered in International Prospective Register of Systematic Reviews (PROSPERO) with identification number CRD42023451794. The literature search was conducted through Pubmed, Proquest, and Google Scholar on August 2023. The inclusion criteria were studies with a population of human subjects, reported the association between Mediterranean diet adherence with risk of COVID-19 infection, COVID-19 symptoms, or COVID-19 severity, and full text must be available in English. The exclusion criteria were reviews, editorials, letters, replies, systematic reviews, meta-analyses, studies on animals, and duplicates. Risk of bias in included studies was assessed using Newcastle Ottawa Scale (NOS). Data was synthesized narratively. Each study was compared and a structured summary was developed. Results: After selection process, 6 articles were included, with a sample size of 55,489 patients. All studies were observational studies and assessed Mediterranean diet adherence using food frequency questionnaires (FFQ), with scoring system varied between each study. Four studies found a significant correlation between increased adherence to Mediterranean Diet and reduced COVID-19 risk, while one study indicated non-significant association. One study reported a significant association between higher adherence to Mediterranean Diet and COVID-19 symptoms, but three studies reported non-significant association. One study found that individuals with higher adherence to Mediterranean Diet had reduced likelihood of developing severe COVID-19, however, two studies yielded inconclusive findings. Limitations: All studies used self-administrated food frequency questionnaires (FFQs), which were prone to biased responses, such as recall and estimation bias. Discussion: Lower trends of odds ratios (ORs) were consistently observed in higher Mediterranean diet adherence. In every outcome of the included studies, ORs ranged between 0.06–0.992, however, differing levels of significance were reported in each outcome. Conclusion: Overall analyses suggest that high adherence to Mediterranean Diet is a protective factor against COVID-19, with unclear benefits against COVID-19 symptoms and severity.

1 July 2022 in F1000Research
Verified
Journal Article
Open access
PDF file
AMAudrey Fabianisa Mirza
Audrey Fabianisa Mirza
CHCeria Halim
Ceria Halim
MSMutiara Indah Sari
Mutiara Indah Sari
Background: SARS-CoV-2 first appeared in Wuhan, China, in December 2019. Looking at the prevalence data in the world and in Indonesia, the highest mortality rate due to COVID-19 involves age, gender and comorbidities such as diabetes mellitus. Severity of the condition also refers to coagulation abnormalities, such as abnormal prothrombin time values. Methods: This systematic review study and meta-analysis used online literature sourced from PubMed, Science Direct, EBSCO, Cochrane and Google Scholar. The literature used here is literature that has data on age, sex and prothrombin time of COVID-19 patients with diabetes mellitus whose quality is assessed by the NOS (Newcastle-Ottawa Scale) criteria and processing data using Review Manager 5.4. Results: Out of 8711 literatures that were traced from various search sources, there were 46 literatures that were included in this study. The results of the analysis on age showed the Standardized Mean Difference (SMD) value of 0.45 and P <0.0001 (95% CI: 0.23–0.68), the gender analysis showed an Odds Ratio (OR) value of 3.28 and P = 0.01 (95% CI: 1.26–8.52) and the prothrombin time analysis showed SMD values of 0.41 and P = 0.07 (95%CI = -0.03–0.85). Conclusion: A person who is infected with COVID-19 and has comorbid diabetes mellitus has a high risk of disease severity and mortality if he is older and male.

24 August 2025 in Global Cardiology Science and Practice
Verified
Journal Article
Open access
PDF file
CHCeria Halim
Ceria Halim
BTBilly Putra Teruna
Billy Putra Teruna
IHIndah Ramadhani Harahap
Indah Ramadhani Harahap
EFEric Teo Fernando
Eric Teo Fernando
LNL. Brianto Christian Nugroho
L. Brianto Christian Nugroho
Introduction and objectives: Heart failure (HF) patients are at risk of developing thrombosis due to low cardiac output, systemic inflammatory response, and endothelial dysfunction. Thromboembolic complications in HF patients most commonly lead to fatal consequences. Methods: The protocol for this study was registered in PROSPERO with identification number CRD42024532861. We performed random-effects meta-analyses on extracted data of hazard ratios (HR) and odds ratios (OR) using Review Manager 5.4. Results: Twenty-two studies with a total population of 14,773 patients were included. INR was associated with risk of mortality (per 0.1 increase, univariate HR = 1.17, 95% CI: 1.08– 1.28, p = 0.0004; multivariate HR = 1.35, 95% CI: 0.80–2.29, p = 0.26). Increased D-dimer significantly increased risk of mortality (per 1 ng/mL increase; univariate HR = 1.87, 95% CI: 1.22–2.89, p = 0.004; multivariate HR = 1.90, 95% CI: 1.09–3.32, p = 0.02), and fibrinogen did not increase risk of mortality (per 1 mg/dL increase; HR = 0.93, 95% CI: 0.77–1.13, p = 0.45). Substantial heterogeneity was observed in D-dimer analyses. Cautious interpretation, noting 95% prediction intervals: 0.75–4.67 (univariate) and 0.58–6.19 (multivariate), should be implemented. Several analyses had insufficient data. Conclusion: Low-certainty evidence weakly supports the potential of D-dimer as an independent prognostic marker in predicting HF mortality.

5 June 2024 in F1000Research
Verified
Journal Article
Open access
PDF file
AMAudrey Fabianisa Mirza
Audrey Fabianisa Mirza
CHCeria Halim
Ceria Halim
MSMutiara Indah Sari
Mutiara Indah Sari
Background SARS-CoV-2 first appeared in Wuhan, China, in December 2019. Looking at the prevalence data in the world and in Indonesia, the highest mortality rate due to COVID-19 involves age, gender and comorbidities such as diabetes mellitus. Severity of the condition also refers to coagulation abnormalities, such as abnormal prothrombin time values. Methods This systematic review study and meta-analysis used online literature sourced from PubMed, Science Direct, EBSCO, Cochrane and Google Scholar. The literature used here is literature that has data on age, sex and prothrombin time of COVID-19 patients with diabetes mellitus whose quality is assessed by the NOS (Newcastle-Ottawa Scale) criteria and processing data using Review Manager 5.4. Results Out of 8711 literatures that were traced from various search sources, there were 46 literatures that were included in this study. The results of the analysis on age showed the Standardized Mean Difference (SMD) value of 0.45 and P <0.0001 (95% CI: 0.23–0.68), the gender analysis showed an Odds Ratio (OR) value of 3.28 and P = 0.01 (95% CI: 1.26–8.52) and the prothrombin time analysis showed SMD values of 0.41 and P = 0.07 (95%CI = -0.03–0.85). Conclusion Older and male COVID-19 patients have a higher risk of having diabetes compared to younger and female COVID-19 patients. As diabetes is a comorbidity in COVID-19, it can be concluded that old age and male sex are associated with a more severe disease.